The signal-transducing Ras proteins are important driving forces of diverse cellular processes such as proliferation, neoplastic transformation, dierentiation and growth inhibition. As a step toward understanding the complex mechanisms underlying cellular responses, gene expression patterns were examined in two phenotypically normal ®broblast lines which dier in their sensitivity toward oncogene-mediated transformation. Suppression subtractive hybridization (SSH) was used to establish a subtracted cDNA library speci®c for the REF52 cell line which, like normal diploid ®broblasts, is refractory toward neoplastic transformation induced by mutated HRAS oncogenes. In contrast, rat 208F control cells can be eciently transformed by HRAS. The nucleotide sequence of 549 subtracted cDNA clones (`REF52 minus 208F') was determined. We identi®ed 93 preferentially expressed gene fragments in resistant REF52 cells as compared to 208F cells. Seventeen of the 52 known genes (32.6%) are capable of inhibiting cell proliferation or of adversely aecting oncogenic signal transduction pathways. These results suggest that the anti-oncogenic properties of resistant REF52 cells are determined by multiple negative growth regulators. The preneoplastic state expressed in 208F cells is characterized by impairment of unexpectedly redundant control mechanisms. Our results also demonstrate that SSH is a powerful method for identifying speci®c transcriptional patterns in closely related cell types.
Introduction
Cellular oncogenes of the Ras family have been identi®ed as critical determinants of malignant phenotypes by virtue of their oncogenic activity in appropriate normal indicator cell lines or in transgenic animals and by their frequent mutational activation in experimental and human tumours (for review see Barbacid, 1987; Bos, 1989; Fowlis and Balmain, 1993) . Since Ras proteins represent a point of convergence for diverse extracellular signals, their eects are not con®ned to the stimulation of proliferation and to the induction of neoplastic transformation in case of mutational activation. Rather, Ras proteins can mediate diverse phenotypes in dierent types of target cells. Introduction of RAS oncogenes into phenotypically normal, immortalized rodent ®broblasts resulted in neoplastic transformation, while diploid embryonic ®broblasts with a ®nite life-span were refractory toward the transforming activity (Land et al., 1983) . In those diploid cells, signal transduction mediated by mutant Ras caused proliferation arrest (Franza et al., 1986; Hirakawa and Ruley, 1988) and activated a premature senescence program accompanied by accumulation of p53 and p16 tumour suppressor proteins (Serrano et al., 1997) . Moreover, Ras proteins were shown to induce dierentiation in PC12 pheochromocytoma cells (BarSagi and Feramisco, 1985; Noda et al., 1985) , F9 teratoma cells (Yamaguchi-Iwai et al., 1990) , medullary thyroid carcinoma cells (Nakagawa et al., 1987) , colon carcinoma cells (Celano et al., 1993) and 3T3 L1 ®broblasts (Benito et al., 1991) . The dierential eects of Ras expression in various cells are mediated by activation of speci®c responsive genes and are determined by the intensity and duration of signalling (Marshall, 1995) . The signalling molecules upstream of Ras involving ligand-bound tyrosine kinase receptors, adapter proteins and guanine nucleotide exchange factors as well as the signalling kinases downstream of Ras have been well characterized. In addition, a number of Ras-responsive target genes involved in cell cycle control and transformation have been analysed in great detail (for review see Malumbres and Pellicer, 1998; Campbell et al., 1998) . However, little is known about the contribution of endogenous gene activity to the diverse cellular responses and about the way how such intrinsic gene functions modulate dierent phenotypic eects mediated by expression of the oncogene.
We wished to elucidate the transcriptional basis of speci®c cellular responses toward RAS oncogenes. Therefore, we sought to compare gene expression patterns in two closely related cell lines, in which Ras signalling induces opposite eects. Immortal rat REF52 cells, like normal murine embryonic fibroblasts, require a mutated RAS gene and a complementary oncogene such as adenovirus E1A, c-myc, N-myc, mutant p53, or large T antigen for full transformation (Franza et al., 1986) . These cells are refractory toward the transforming activity of RAS alone (Serrano et al., 1997) . In contrast, 208F ®broblasts can be eciently transformed by mutated RAS, like mouse 3T3 cells (Griegel et al., 1986) . Assuming that RAS-resistant REF52 cells express negative growth regulators, which are lacking in transformation-sensitive 208F fibroblasts, we established a REF52-speci®c mRNA expression pro®le with the help of a subtracted cDNA library. To selectively amplify target (tester) cDNA fragments representing genes preferentially expressed in REF52 cells, we used suppression subtractive hybridization (SSH), a PCR-based cDNA subtraction method (Diatchenko et al., 1996) . The SSH strategy equalized sequence abundance during cDNA subtraction and allowed ecient representation of both rare and highly abundant REF-52-speci®c transcripts. The amplification of non target (driver) cDNA obtained from 208F cells was simultaneously suppressed. The sequence of 549 cDNA clones was determined and compared to public databases. The preferential expression in REF52 cells of known genes, expressed sequence tags and novel sequences was con®rmed by Northern blot analysis.
Here we provide evidence for the preferential expression in REF-52 cells of multiple genes capable of constraining growth and of suppressing transformation. Consequently, the susceptibility toward oncogenic signalling involves the repression of these factors.
Results
Complementary cDNA clones representing transcripts preferentially expressed in REF52 cells, which are refractory toward RAS oncogene-induced transformation, were recovered from a subtracted cDNA library constructed as described in Materials and methods. For the preparation of tester cDNA we used mRNA from REF-52 cells. Driver cDNA prepared from transformation-sensitive 208F cells was used in excess during cDNA subtraction. Prior to RNA isolation, we con®rmed the oncogene resistance of REF52 cells. Calciumphosphate/DNA coprecipitates carrying a resistance gene and mutant HRAS or v-src plasmid DNA, respectively, were transfected in parallel onto REF52 cells and the susceptible rat ®broblast line Rat-2. While both oncogenes induced morphological transformation in Rat-2 cells, no transformed REF52 transfectants were obtained (Table 1) . We determined the nucleotide sequence of 549 subtracted cDNA clones and identi®ed 382 individual sequences. Subsequently, the dierential expression of all transcripts represented in the subtracted cDNA library was analysed by reverse or conventional Northern blot hybridization. Complementary DNA inserts were re-ampli®ed by PCR using nested adapter primers. PCR products were gel-fractionated and blotted. Duplicate blots were hybridized with 32 P-labelled REF52 and 208F cDNA probes of equal speci®c activity, respectively. In addition, 55 selected cDNA fragments were used as probes for Northern analysis of REF52 and 208F mRNA (Figure 1 ). Ninety-three of 273 dierent gene fragments (34%) were found to be preferentially expressed in REF52 cells. Most of them represent known genes and expressed sequence tags ( Figure 1 Northern blot analysis of genes identi®ed in the subtracted REF52 cDNA library. Total RNA was prepared from REF52 (RR, resistant to ras-mediated transformation) and 208F (RS, susceptible) cells. Transcript sizes (in kb) correspond to published observations. Dierences in REF52 mRNA steady-state levels relative to 208F mRNA were estimated as 420-fold for SSeCKs, b-NGF, sim2, EST r46969, EST hsw26443, clone 102 without match to database, as 5 ± 10-fold for mac25, TSP1, and 2 ± 5-fold for hic-5, CUL-1,
expressed genes as reported previously (Zhang et al., 1997; Chang et al., 1998) . Thus, we conclude that the cDNA fragments obtained in this study represent a signi®cant fraction of genes dierentially regulated in the two phenotypically normal REF52 and 208F cell lines.
Discussion
We identi®ed 52 genes preferentially expressed in transformation-resistant REF52 cells relative to susceptible 208F ®broblasts. The transcripts of eight of these genes were not detectable in transformationsensitive 208F cells by reverse Northern blotting of arrayed cDNA inserts or by Northern analysis of total RNA. Transcript levels of the remaining 44 genes were reduced 3 ± 20-fold in 208F cells. This suggests that the susceptibility toward oncogene-mediated transformation in 208F cells is closely associated with losses of multiple gene functions. Although reduced mRNA levels may still suce for the synthesis of the encoded proteins in 208F cells, diminished transcription is likely to play an important role in the susceptibility toward oncogenic transformation as well. Seventeen of the 52 known genes preferentially expressed in REF52 cells are strong candidates for a causal role in oncogeneresistance, because their products are capable of inhibiting signal transduction, mitogenesis or neoplastic transformation in various cell types (Table 4 and references therein). One example is the SSeCKs gene which encodes the major protein kinase C binding protein previously identi®ed in REF52 cells (Chapline et al., 1996) . Forced expression of SSeCKs in transformed cells resulted in suppression of morphological transformation and tumorigenesis (Lin and Gelman, 1997) . A second example is the product of the MEK2 gene which is a target of the Ras suppressor protein Rsu-1 (Masuelli and Cutler, 1996) . Moreover, junB coexpression antagonizes focus formation in cells transfected with complementary ras and c-jun oncogenes (SchuÈ tte et al., 1989; Chiu et al., 1989) . Cells expressing the cx43 gene inhibit growth of co-cultured ras-transformed cells via gap junctional communication (Esinduy et al., 1995) . In addition, annexin VI suppresses growth of A431 cells overexpressing the EGF receptor, which is upstream of Ras in the signal transduction pathway (Theobald et al., 1995) . Five genes, TSP1 (Murano et al., 1991) , hic-5 (Shibanuma et al., 1994) , mac25 (Swisshelm et al., 1995) , sm22 (Gonos et al., 1998), and WRN (Yu et al., 1996) , all of them preferentially expressed in REF52 cells, are associated with cellular senescence, which is regarded as a major mechanism of tumour suppression (O'Brien et al., 1986) . Other genes may similarly contribute to transformation-related growth constraints in REF52 cells, although their precise role in ®broblast-like cells
is not yet known: REF52 cells dier from 208F cells in the preferential expression of sequences encoding products associated with neuronal functions. These include the prion protein, the neuron-speci®c growthassociated protein SCG10, a retina-speci®c sequence (W26443) and two ESTs identi®ed in rat PC12 pheochromocytoma cells treated with nerve growth factor (H35700, AA686344). REF52 cells contained elevated mRNA levels of the genes encoding nerve growth factor-b and Rip(p116), which are able to induce neuronal dierentiation via the Ras and RhoA signalling pathways, respectively. These data suggest a growth-constraining role of multiple genes via the control of transcription, signal transduction, and intercellular communication. Some of the factors expressed preferentially in REF52 cells may impinge on each other. For example, the SSeCKs gene was shown to induce MEK2 activity and to reverse the reduction of vinculin-associated adhesion plaques in vsrc-transformed ®broblasts (Lin and Gelman, 1997) .
The role of REF52-speci®c genes in negative growth regulation is supported by the absence of their expression in tumorigenic cells. The SSeCKs gene is down-regulated in cells transformed by ras and src oncogenes (Lin et al., 1995) . The functional loss of annexin VI (Theobald et al., 1995) , hic-5 (Shibanuma et al., 1994) , mac25 (Swisshelm et al., 1995) , PRSS11 (Zumbrunn and Trueb, 1996) , vinculin (Fernandez et al., 1992) , and sm22 (Gonos et al., 1998) genes was originally detected in transformed cells. Our results indicate that the downregulation of these genes is not correlated with the acquisition of neoplastic properties, since 208F cells continue to express the normal phenotype despite diminished expression. Rather, loss or reduction of transcription is associated with the susceptibility toward transformation.
In addition to the 52 sequences with known function, 25 expressed sequence tags and 16 novel cDNAs recovered in the subtracted cDNA library represent genes which are preferentially expressed in REF52 cells. In view of the abundance of mRNAs encoded by negative growth regulators, at least some of the corresponding novel genes may serve similar functions. Thus, the pattern of genes related to oncogene-resistance in REF52 cells may be even more complex. The transformation-suppressing role of individual genes discussed above has already been demonstrated in various cell systems. Although these ®ndings suggest a similar role for these genes in REF52 cells, they do not provide ultimate proof for a causal role of multiple rather than individual factors in oncogene-resistance. This would rather require reconstruction experiments, in which expression of multiple genes is restored in 208F cells to levels found in REF52 cells. However, technical obstacles exist for the simultaneous or stepwise transfer of multiple genes into the same recipient cells.
The distinct gene expression pro®les of cells resistant and susceptible to oncogene-induced transformation may be controlled by a limited set of regulatory genes. Transcription factors that stimulate the transcription of multiple growth-constraining genes in REF52 cells may function inappropriately in 208F cells. Alternatively, M87276  D84068  U23146  X53416  X60111  AF043326  D50093  U12309  X02918  X71070  X92474  Z50115  AA948238  AF040965  AJ222586  D17614  D86526  D87258  D89290  J02640  L07049  L14936  L18880  L19713  L22482  L35767  L75822  M19317  M36589  M70642  M77174  M81894  M83681  M90514  M95780  MMU43512  S82024  U37283  U51584  U58087  U65928  U66322  U73200  U80456  X05884  X54510  X54686  X65026  X65603  X93352  X86086 (Table 3) . At least some of the critical determinants of oncogene-resistance in REF52 cells may be controlled by the transcriptional regulators p53 and interferon-regulatory factor 1 (IRF-1), since their genetic ablation predisposes embryonic ®broblasts to transformation by oncogenes (Tanaka et al., 1994) . Tsp-1 expression is indeed positively regulated by the p53 protein and shut o when the protein is mutated and Trueb, 1996) 5 ± 10 fold Vinculin Protein associated with adhesion plaques and cell-cell contacts, suppresses transformed phenotypes in SV40-transformed 3T3 cells and BSp73ASML rat adenocarcinoma cells (Fernandez et al., 1992) 
CD9/MRP1
Trans-membrane glycoprotein, suppresses cell growth and motility in lung carcinoma cells and metastasis in melanoma cells (Ikeyama et al., 1993) 
sm22/transgelin
Actin gelling protein, downregulated in ras transformed cells, induced in senescent rat embryo ®broblasts (Gonos et al., 1998) TSP1 Thrombospondin 1, multifunctional extracellular matrix protein, suppresses proliferation in vitro and in vivo of mouse endothelial cells transformed by Polyoma virus (Sheibani and Frazier, 1995) and tumorigenicity of 3T3 cells transformed by v-src (Castle et al., 1997) Mac25/IGFPB-7
Insulin-like growth factor binding protein 7, suppresses growth of Saos-2 osteosarcoma cells (Kato et al., 1996) Annexin VI Calcium-binding protein, suppresses growth of A431 cells in vivo (Theobald et al., 1995) 
MEK2
Serine/threonine kinase, activated by Ras suppressor protein rsu-1 (Masuelli and Cutler, 1996) 55-fold* Hic-5 LIM double zinc ®nger protein, reduces colony formation of non-transformed ®broblasts (Shibanuma et al., 1994 ) WRN Helicase-like protein, associated with the phenotype of premature ageing (Werner syndrome) (Yu et al., 1996) Gap junctional protein, inhibits growth of glioma cells (Zhu et al., 1992) and of H-ras and neutransformed cells by intercellular communication (Esinduy et al., 1995) Cul-1(lin-19) Cullin, component of ubiquitin ligase complex, regulates cell cycle exit; null mutation causes hyperplastic tissue growth in C. elegans (Kipreos et al., 1996) Rip (p116) Rho A-interacting protein, promotes neurite formation in neuronal N1E-115 cells (Gebbink et al., 1997) *-fold steady-state mRNA level in REF52 relative to 208F cells UI-R-C0-hi-g-12-0-UI.s1 UI-R-C0 rat embryo UI-R-C0-hj-b-04-0-UI.s1 UI-R-C0 rat embryo EST212098 normalized rat embryo ub77c05.r1 Soares mouse mammary gland C06842 rat pancreatic islet Y219 rat incisor (noncalci®ed tissues) md48c05.r1 Soares mouse embryo me85g03.r1 Soares mouse embryo
Novel genes
16 sequences with no match in database R,N
The dierential expression of all genes listed was con®rmed by Northern analysis. R, reverse Northern blot using DNA array; N, conventional Northern blot. The Werner syndrome and junB genes were detectable by RT ± PCR only (Dameron et al., 1994) . In contrast, mac25 expression is unaected by the loss of wild-type p53 functions (Kato et al., 1996) . Characterization of the regulatory sequences of REF52-speci®c genes will aid in de®ning the physiologically relevant transcription factors. It is becoming increasingly clear that normal development and pathological conditions involve complex alterations of gene activity. Accordingly, novel high through-put techniques are being developed, capable of simultaneously monitoring the activity of thousands of genes and ®nally of assessing the entire set of transcription units in the genome (Strachan et al., 1997) . The SSH method provides an interesting alternative to other genome-wide screening strategies for several reasons: The cDNA subtraction provides an approximately 1000-fold enrichment (Diatchenko et al., 1996) of known and novel candidate genes related to de®ned phenotypes, since recovery of common (non dierential) sequences is eciently suppressed. Consequently, limited sequencing capacities are sucient for characterizing relatively small but speci®c sets of transcriptionally altered genes. In contrast to the SAGE method (Zhang et al., 1997; Madden et al., 1997) , SSH provides considerably long cDNA sequences (100 ± 700 base pairs) rather than short sequence tags. Novel sequences obtained by SSH are of sucient length to permit searching for homologies and common motifs of predicted translation products. The speci®c expression pro®les obtained by SSH can be subjected to quantitative and automated analysis on a limited number of cDNA arrays, but do not require expensive microchip technology. In summary, gene expression pro®ling of transformation-resistant cells has provided novel insights into the complex transcriptional changes underlying the preneoplastic state and identi®ed potential markers for the early onset of transformation. This method is a powerful tool for the analysis of complex expression dierences between normal and tumour cells and for alterations involved in dierentiation, development, and disease.
Materials and methods

Cell lines and transfection
Cells were cultured in Dulbecco's Modi®ed Eagle's Medium supplemented with 10% foetal calf serum. Transfections were done by the calcium-phosphate precipitation method as described (Griegel et al., 1986) . One million cells each were exposed to a coprecipitate of 1 mg pY3 DNA carrying the hygromycin B phosphotransferase gene (Blochlinger and Diggelmann, 1984) , 10 mg high-molecular-weight Rat-2 carrier DNA, and 10 mg T24-ras plasmid DNA harbouring the activated HRAS gene from T24 bladder carcinoma cells (Reddy et al., 1982) , or 10 mg pMV3/ASVsrc plasmid DNA harbouring the v-src oncogene (DeLorbe et al., 1980) , respectively. The number of transformed foci was determined in con¯uent cultures propagated for 2 ± 3 weeks after transfection. Eciency of transfection was determined in parallel cultures by counting resistant colonies obtained in selective medium with 400 mg/ml hygromycin B.
Construction of subtracted cDNA library
Messenger RNA obtained from subcon¯uent cells was isolated using the Separator Kit (Clontech, Palo Alto, CA, USA), cDNA synthesis and subtraction were performed using the PCR-select TM cDNA subtraction kit (Clontech, Palo Alto, CA, USA) according to manufacturer's protocol. Tester cDNA was synthesized from transformation-resistant REF52 cells, driver cDNA from transformation-sensitive 208F cells. The eciency of cDNA subtraction was evaluated by comparing the levels of sequences of the housekeeping gene GAPDH in subtracted and control REF52-speci®c cDNA using RT ± PCR. Detectable ampli®cation of GAPDH sequences required 33 PCR cycles using subtracted REF52 cDNA as template, while only 18 cycles were sucient when using control cDNA. Subtracted cDNA sequences were puri®ed with the help of the PCR Clean Up Kit (Boehringer Mannheim), and 20 ng of the subtraction mixture were inserted into PCR2.1 by T/A cloning (Invitrogen, Leek, The Netherlands). Individual transformants carrying cDNA fragments were isolated from white colonies on X-gal/IPTG agar plates. To assess the quality of the library with respect to redundancy and speci®city, DNA was isolated from 20 randomly picked cDNA transformants and sequenced. Dierential expression of the inserted sequences was analysed on Northern blots with total RNA from REF52 and 208F cells.
Northern blot analysis
Reverse Northern blotting of all cDNA fragments obtained was done as described (von Stein et al., 1997) except for dierent hybridization conditions. For prehybridization of membranes, we used 56Denhardt's reagent, 56SSC, 50 mM phosphate buer, 0.5% SDS, 100 ng/ml tRNA at 658C for 3 h. Hybridization was performed in the same buer without Denhardt's reagent and 50 mM phosphate buer at 658C for 16 h. For conventional Northern blot analysis, 10 mg of total RNA were fractionated by electrophoresis through 1% agarose gels containing formaldehyde and blotted in 206SSC onto Protran nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany). The cDNA fragments were labelled with 32 P-dCTP using the ReadyPrime system (Amersham, Braunschweig). Hybridization was performed in formamide buer (50% formamide, 56Denhardt's reagent, 56SSC, 0.1% SDS, 100 mg/ml yeast tRNA) at 428C overnight. Membranes were washed three times in 26SSC, 0.1% SDS at 428C for 15 min; twice in 0.16SSC, 0.1% SDS at 428C; and ®nally in 0.16SSC, 0.1% SDS at 608C for 30 min. Washed membranes were exposed to X-ray ®lms at 7808C for 6 h ± 3 days.
Sequence analysis
Sequencing of cDNA inserts was accomplished by PCR using the Thermo Sequenase kit (Amersham, Braunschweig) and a LI-COR sequencer. Sequence homology searches were conducted using the BLASTN program against the NCBI Non-Redundant and EST databases (http://www.ncbi.nlm.nih.gov/). Homology to a database sequence was de®ned as sequence identity 495% over a region of 50 ± 400 bp depending on cDNA insert length. Clones which failed to match any existing public database entry (as of January 1999) are denoted as novel.
Note added in proof
Sequence homology searches were repeated in July 1999. EST AA943639 has now been identi®ed as M. musculus protocadherin 2C (accession no. NMU88550) and EST W78518 is H. sapiens ubiquitin protease 7 (accession no. NM_003470.1).
